Search information pages
About Journal of Inflammation
This page includes information about the aims and scope of Journal of Inflammation, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Journal of Inflammation welcomes research submissions on all aspects of inflammation. Non-research articles are specially commissioned by the Editors-in-Chief.
Journal of Inflammation is an open access, peer-reviewed online journal publishing articles on all aspects of research into inflammation.
The five classical symptoms of inflammation, namely redness (rubor), swelling (tumour), heat (calor), pain (dolor) and loss of function (functio laesa), are only part of the story. The term inflammation is taken to include the full range of underlying cellular and molecular mechanisms involved, not only in the production of the inflammatory responses but, more importantly in clinical terms, in the healing process as well. Thus the journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings.
Journal of Inflammation aims to become the leading online journal on inflammation and, as online journals replace printed ones over the next decade, the main open access inflammation journal. Open access guarantees a larger audience, and thus impact, than any restricted access equivalent, and increasingly so, as the escalating costs of printed journals puts them outside University budgets. The unrestricted access to research findings in inflammation aids in promoting dynamic and productive dialogue between industrial and academic members of the inflammation research community, which plays such an important part in the development of future generations of anti-inflammatory therapies.
All articles published by Journal of Inflammation are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in Journal of Inflammation are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Journal of Inflammation therefore levies an article-processing charge of £1245/$2085/€1500 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.
All articles published in Journal of Inflammation are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Journal of Inflammation include:
- Biological Abstracts
- Current contents
- Global Health
- Google Scholar
- Index Copernicus
- PubMed Central
- Science Citation Index Expanded
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).
The full text of all research articles published by BioMed Central is also available on SpringerLink.
Journal of Inflammation is tracked by Thomson Reuters (ISI) and has an Impact Factor of 2.55.
Publication and peer review process
Journal of Inflammation considers the following types of articles:
- Research: reports of data from original research.
- Commentaries: Specially commissioned by Editors-in-Chief - short, focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue, such as recent research findings. They focus on specific issues and are about 800 words.
- Hypothesis: Specially commissioned by Editors-in-Chief - short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable, and be about 1500 words.
- Reviews: Specially commissioned by Editors-in-Chief - comprehensive, authoritative, descriptions of any subject within the journal's scope. They have an educational aim and are 2000-3000 words.
Journal of Inflammation has a closed peer review process, meaning that referees' confidentiality is maintained and referees reports are not made publicly available. Each article submitted is reviewed by at least two independent reviewers. We aim to review and make decisions as quickly as possible.
Prior to January 2010 the journal operated under a policy of open peer review, meaning that a 'pre-publication history' including signed reviews was published alongside the articles. If you wish to request details of the pre-publication history for an article published during this time, please contact email@example.com.
Edited by Paul Kirkham and Dennis Taub, Journal of Inflammation is supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Journal of Inflammation, a personalized section of the site.
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Journal of Inflammation will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
All manuscripts submitted to Journal of Inflammation should adhere to BioMed Central's editorial policies.
Citing articles in Journal of Inflammation
Articles in Journal of Inflammation should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. J Inflamm [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J Inflamm 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Journal of Inflammation?
Journal of Inflammation's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Journal of Inflammation offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Journal of Inflammation, BioMed Central and PubMed Central and will also be included in PubMed.
Online publication in Journal of Inflammation gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Journal of Inflammation are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Journal of Inflammation's pages and on the BioMed Central homepage.
In addition, articles published in Journal of Inflammation may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Journal of Inflammation. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in Journal of Inflammation retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.